| Issue Date | Title | Author(s) |
| 2023-05-17 | Delivery of PEGylated liposomal doxorubicin by bispecific antibodies improves treatment in models of high-risk childhood leukemia. | Moles, E; Howard, CB; Huda, P; Karsa, M; McCalmont, H; Kimpton, K; Duly, A; Chen, Y; Huang, Y; Tursky, ML; Ma, D; Bustamante, S; Pickford, R; Connerty, P; Omari, S; Jolly, CJ; Joshi, S; Shen, S; Pimanda, JE; Dolnikov, A; Cheung, LC; Kotecha, RS; Norris, MD; Haber, M; de Bock, CE; Somers, K; Lock, RB; Thurecht, KJ; Kavallaris, M |
| 2023-04-01 | Inhibition of mitochondrial translocase SLC25A5 and histone deacetylation is an effective combination therapy in neuroblastoma. | Seneviratne, JA; Carter, DR; Mittra, R; Gifford, A; Kim, PY; Luo, J-S; Mayoh, C; Salib, A; Rahmanto, AS; Murray, J; Cheng, NC; Nagy, Z; Wang, Q; Kleynhans, A; Tan, O; Sutton, SK; Xue, C; Chung, SA; Zhang, Y; Sun, C; Zhang, L; Haber, M; Norris, MD; Fletcher, JI; Liu, T; Dilda, PJ; Hogg, PJ; Cheung, BB; Marshall, GM |
| 2023-04-03 | A novel transcriptional signature identifies T-cell infiltration in high-risk paediatric cancer. | Mayoh, C; Gifford, AJ; Terry, R; Lau, LMS; Wong, M; Rao, P; Shai-Hee, T; Saletta, F; Khuong-Quang, D-A; Qin, V; Mateos, MK; Meyran, D; Miller, KE; Yuksel, A; Mould, EVA; Bowen-James, R; Govender, D; Senapati, A; Zhukova, N; Omer, N; Dholaria, H; Alvaro, F; Tapp, H; Diamond, Y; Pozza, LD; Moore, AS; Nicholls, W; Gottardo, NG; McCowage, G; Hansford, JR; Khaw, S-L; Wood, PJ; Catchpoole, D; Cottrell, CE; Mardis, ER; Marshall, GM; Tyrrell, V; Haber, M; Ziegler, DS; Vittorio, O; Trapani, JA; Cowley, MJ; Neeson, PJ; Ekert, PG |
| 2023-10-25 | Mitotic Dysregulation at Tumor Initiation Creates a Therapeutic Vulnerability to Combination Anti-Mitotic and Pro-Apoptotic Agents for MYCN-Driven Neuroblastoma. | Zhai, L; Balachandran, A; Larkin, R; Seneviratne, JA; Chung, SA; Lalwani, A; Tsubota, S; Beck, D; Kadomatsu, K; Beckers, A; Durink, K; De Preter, K; Speleman, F; Haber, M; Norris, MD; Swarbrick, A; Cheung, BB; Marshall, GM; Carter, DR |
